Evidence map›Paper›PMID 27514669›Full record

ArticleMicrobial cell factories2016

Mycobacterium tuberculosis H37Ra: a surrogate for the expression of conserved, multimeric proteins of M.tb H37Rv.

Vishant Mahendra Boradia, Pravinkumar Patil, Anushri Agnihotri, Ajay Kumar, Kalpesh Kumar Rajwadi, Ankit Sahu, Naveen Bhagath, Navdeep Sheokand, Manoj Kumar, Himanshu Malhotra and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Repurposing ethyl bromopyruvate as a broad-spectrum antibacterial.The Journal of antimicrobial chemotherapy · 2019
    Article
  3. Frontiers in cellular and infection microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Vishant Mahendra BoradiaNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Pravinkumar PatilNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Anushri AgnihotriNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Ajay KumarNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Kalpesh Kumar RajwadiNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Ankit SahuNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Naveen BhagathNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Navdeep SheokandCouncil of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Sector 39 A, Chandigarh, 160036, India.
Manoj KumarCouncil of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Sector 39 A, Chandigarh, 160036, India.
Himanshu MalhotraCouncil of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Sector 39 A, Chandigarh, 160036, India.
Rachita PatkarNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Navi HasanNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India.
Manoj RajeCouncil of Scientific and Industrial Research-Institute of Microbial Technology (CSIR-IMTECH), Sector 39 A, Chandigarh, 160036, India.
Chaaya Iyengar RajeNational Institute of Pharmaceutical Education and Research (NIPER), Phase X, Sector 67, SAS Nagar, Punjab, 160062, India. chaaya@niper.ac.in.
National Institute of Pharmaceutical Education and Research · INCouncil of Scientific and Industrial Research · INInstitute of Microbial Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObtaining sufficient quantities of recombinant M.tb proteins using traditional approaches is often unsuccessful. Several enzymes of the glycolytic cycle are known to be multifunctional, however relatively few enzymes from M.tb H37Rv have been characterized in the context of their enzymatic and pleiotropic roles. One of the primary reasons is the difficulty in obtaining sufficient amounts of functionally active protein.

resultsIn the current study, using M.tb glyceraldehyde-3-phosphate dehydrogenase (GAPDH) we demonstrate that expression in E. coli or M. smegmatis results in insolubility and improper subcellular localization. In addition, expression of such conserved multisubunit proteins poses the problem of heteromerization with host homologues. Importantly the expression host dramatically affected the yield and functionality of GAPDH in terms of both enzymatic activity and moonlighting function (transferrin binding). The applicability of this system was further confirmed using two additional enzymes i.e. M.tb Pyruvate kinase and Enolase.

conclusionsOur studies establish that the attenuated strain M.tb H37Ra is a suitable host for the expression of highly hydrophobic, conserved, multimeric proteins of M.tb H37Rv. Significantly, this expression host overcomes the limitations of E. coli and M. smegmatis expression and yields recombinant protein that is qualitatively superior to that obtained by traditional methods. The current study highlights the fact that protein functionality (which is an an essential requirement for all in vitro assays and drug development) may be altered by the choice of expression host.

Indexed as

Protein MultimerizationBacterial ProteinsEscherichia coliGlyceraldehyde-3-Phosphate DehydrogenasesMultienzyme ComplexesMycobacterium smegmatisMycobacterium tuberculosisPhosphopyruvate HydratasePyruvate KinaseRecombinant ProteinsSolubilityTransferrinBacterial ProteinsGlyceraldehyde-3-Phosphate DehydrogenasesMultienzyme ComplexesPhosphopyruvate HydratasePyruvate KinaseRecombinant ProteinsTransferrin

Identifiers

PMID27514669
PMCPMC4982137
OpenAlexW2518458201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.